Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Hypogammaglobulinemia
Hypogammaglobulinemia, Acquired
Interventions
DRUG:
IgPro20
Sponsor
Memorial Sloan Kettering Cancer Center